This study is currently not recruiting participants.

A Phase IIa Multicenter Double-Blind Placebo-Controlled Parallel-Group Clinical Trial to Evaluate the Safety and Efficacy of MK-6096 in Patients with Painful Diabetic Neuropathy

Investigation of Safety and Tolerability of Investigational Medication

Not Recruiting
18 years - 65 years
All
Phase N/A
1 Location

Brief description of study.

The purpose of this study is to test the safety and tolerability of the research study drug, MK-6096.

Detailed description of study

The purpose of this study is to test the safety and tolerability of the research study drug, MK-6096.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Diabetic Neuropathy
  • Age: 18 years - 65 years
  • Gender: All

This study investigates the safety and tolerability of an investigational medication. Safety refers to how the body handles the medication and any side effects it may cause. Tolerability is about how well participants can manage any side effects.

Participants in the study will receive the investigational medication under close supervision. Researchers will monitor participants for any side effects and assess how the medication is processed in the body.

  • Who can participate: Eligibility criteria are not specified. Please contact the study team for more information on participant requirements.
  • Study details: Participants will be given the investigational medication and monitored for side effects. Researchers will check how the medication is absorbed and processed by the body.
Updated on 19 Feb 2024. Study ID: 1206008866

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team